Thank you for your reading and interest in the news Ibuprofen, once thought to worsen coronavirus, now being tested as a treatment and now with details
Hind Al Soulia - Riyadh - Scientists in London are trialling everyday, low-cost painkiller Ibuprofen for coronavirus treatment in the belief that its anti-inflammatory properties could help with breathing problems.
A team from St Thomas' hospital and Kings College hope the drug could keep patients off ventilators and are trialling half of their patients with a special liquid for of Ibuprofen used to treat arthritis.
Animal studies have suggested the lipid capsule form of the drug might treat acute respiratory distress syndrome, which is one of the complications of severe coronavirus.
It was initially feared in the early stages of the pandemic that Ibuprofen had a negative effect on coronavirus due to a small study but subsequent research disproved that.
More than 10,000 human subjects in the UK are also being recruited for advanced studies into a potential Covid-19 vaccine.
Companies and academics around the world are racing to find medicines for the coronavirus.
The US has already pledged up to US$1.2 billion to AstraZeneca to develop the vaccine it is trialling with Oxford University.
AstraZeneca said it planned to make as many as 30 million doses available in Britain from as early as September.
In the UK trial, adult subjects will be randomly selected to receive one or two doses of either the Oxford drug or an already licensed vaccine against meningitis for comparison.
Volunteers will record their reactions in an e-diary and attend follow-up visits. Some will be given swabs for taking samples at home.
A smaller part of the trial will expand the age range of testing to include children aged from 5 to 12 years old and adults 56 and older. The other, larger group will be studied to test the vaccine’s effectiveness in volunteers 18 and older.
Updated: June 3, 2020 01:04 PM
These were the details of the news Ibuprofen, once thought to worsen coronavirus, now being tested as a treatment for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at The National and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.